Market revenue in 2022 | USD 381.1 million |
Market revenue in 2030 | USD 686.2 million |
Growth rate | 7.6% (CAGR from 2022 to 2030) |
Largest segment | Evaporative dry eye syndrome |
Fastest growing segment | Evaporative Dry Eye Syndrome |
Historical data covered | 2018 - 2021 |
Base year for estimation | 2022 |
Forecast period covered | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Evaporative Dry Eye Syndrome, Aqueous Deficient Dry Eye Syndrome |
Key market players worldwide | Novartis AG ADR, AbbVie Inc, Sun Pharmaceutical Industries, Santen Pharmaceutical Co Ltd, Johnson & Johnson, Otsuka Pharmaceutical, OASIS Medical, Bausch & Lomb Corp, AFT Pharmaceuticals, Oyster Point Pharmaceuticals |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dry eye syndrome treatment market will help companies and investors design strategic landscapes.
Evaporative dry eye syndrome was the largest segment with a revenue share of 82.6% in 2022. Horizon Databook has segmented the Latin America dry eye syndrome treatment market based on evaporative dry eye syndrome, aqueous deficient dry eye syndrome covering the revenue growth of each sub-segment from 2018 to 2030.
Latin America region includes rapidly evolving economies, including Brazil and Mexico. Increasing R&D activities, coupled with rapid technological advancements in the region, are anticipated to fuel market growth. Increasing government spending, growing investments by major pharmaceutical & biopharmaceutical companies, and presence of major academic research institutes are factors likely to promote market growth.
Increase in the incidence of dry eye disease leading to poor quality of life is expected to boost the market. Supportive government initiatives and research collaborations are anticipated to contribute to market growth. As per the International Monetary Fund, in 2018, the public health expenditure in the region averaged 4.4% of GDP, which, when compared to the demographic profile, is higher than in other regions.
In addition, medical cost per person tends to escalate as they age. The region's growing geriatric population is, therefore, expected to act as a market driver.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America dry eye syndrome treatment market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America dry eye syndrome treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account